Related Experiment Video
Updated: Jan 7, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Human Papillomavirus-Related Anal Precancerous Lesions in Men Who Have Sex With Men: A Comparative Study of
Magali Surmont1,2, Michel Verheyden3, Shaira Sahebali4
1Department of Gastroenterology and Hepatology, UZ Brussel, Brussels, Belgium.
Background:
Although anal cancer is rare, it disproportionately affects high-risk groups such as men who have sex with men (MSM) and people with human immunodeficiency virus (HIV). MSM using Pre-Exposure Prophylaxis (MSM-PrEP) represent an emerging subgroup with behavioral risk factors that may increase susceptibility to High-Risk Human Papillomavirus (HRHPV) infection and anal High-grade Squamous Intraepithelial Lesions (HSIL). However, data on precancerous anal lesions in this group remain unexplored.This study aims to compare the prevalence and distribution of histological abnormalities detected by High-Resolution Anoscopy (HRA) between MSM-PrEP and MSM with HIV (HIV + MSM) and to explore the association between anal HSIL and anal swab results using cytology and HRHPV testing.
Methods:
This secondary exploratory analysis extended a prospective, monocentric cross-sectional study on cytology and HPV infection conducted at the HIV Reference Centre and PrEP Clinic of Universitair Ziekenhuis Brussel by incorporating histological data.
Results:
A total of 85 MSM-PrEP and 93 HIV + MSM underwent HRA. Histologically confirmed anal HSIL did not differ significantly between MSM-PrEP and HIV + MSM (OR 0.6, 95% CI .32-1.25). No significant variation was observed in the overall histological outcome distribution (P = .401). A history of gonorrhea was significantly associated with HSIL (OR 2.39, 95% CI 1.03-5.55). Cytology showed limited discriminatory value, while HRHPV infection was present in all HSIL cases. Many lesions were linked to HRHPV types other than HPV16.
Conclusions:
MSM-PrEP may be at similarly high risk for anal HSIL as HIV + MSM, underscoring the need for tailored screening strategies.
Insights
Men who have sex with men using Pre-Exposure Prophylaxis (MSM-PrEP) may face anal high-grade squamous intraepithelial lesions (HSIL) risks similar to those with HIV. Tailored screening for anal cancer in MSM-PrEP is crucial.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Anal cancer disproportionately affects men who have sex with men (MSM) and people with HIV.
- MSM using Pre-Exposure Prophylaxis (MSM-PrEP) are an emerging subgroup with potential risk factors for high-risk human papillomavirus (HR HPV) infection and anal HSIL.
- Data on precancerous anal lesions in MSM-PrEP are currently limited.
Purpose of the Study:
- To compare the prevalence and distribution of histological abnormalities via high-resolution anoscopy (HRA) between MSM-PrEP and MSM with HIV (HIV+MSM).
- To explore the association between anal HSIL and anal swab results using cytology and HR HPV testing.
Main Methods:
- Secondary exploratory analysis of a prospective, monocentric cross-sectional study.
- Inclusion of histological data from 85 MSM-PrEP and 93 HIV+MSM.
- Analysis of HRA findings, cytology, and HR HPV testing results.
Main Results:
- No significant difference in histologically confirmed anal HSIL prevalence between MSM-PrEP and HIV+MSM (OR 0.6).
- A history of gonorrhea was significantly associated with HSIL (OR 2.39).
- HR HPV infection was detected in all HSIL cases, with many lesions linked to non-HPV16 types; cytology showed limited discriminatory value.
Conclusions:
- MSM-PrEP may be at a similar risk for anal HSIL as HIV+MSM.
- The findings highlight the need for tailored anal cancer screening strategies for MSM-PrEP.
- Further research into HR HPV types and their role in anal lesions within this population is warranted.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...